Bigul

Vineet Laboratories Ltd - 543298 - Format of the Initial Disclosure to be made by an entity identified as a Large Corporate : Annexure A

Format of Initial Disclosure to be made by an entity identified as a Large Corporate. Sr. No. Particulars Details 1Name of CompanyVineet Laboratories Ltd 2CIN NO.L24304TG2016PLC112888 3 Outstanding borrowing of company as on 31st March / 31st December, as applicable (in Rs cr) 40.01 4Highest Credit Rating during the previous FY NA 4aName of the Credit Rating Agency issuing the Credit Rating mentioned in (4)Not Applicable 5Name of Stock Exchange# in which the fine shall be paid, in case of shortfall in the required borrowing under the frameworkBSE We confirm that we are a Large Corporate as per the applicability criteria given under the SEBI circular SEBI/HO/DDHS/CIR/P/2018/144 dated November 26, 2018. No Name of the Company Secretary: Ramesh Kumar Bandari Designation: Company Secretary and Compliance Officer EmailId: [email protected] Name of the Chief Financial Officer: Satyanarayana Raju Bhupathiraju Designation: Chief Financial Officer EmailId: [email protected] Date: 22/04/2024 Note: In terms para of 3.2(ii) of the circular, beginning F.Y 2022, in the event of shortfall in the mandatory borrowing through debt securities, a fine of 0.2% of the shortfall shall be levied by Stock Exchanges at the end of the two-year block period. Therefore, an entity identified as LC shall provide, in its initial disclosure for a financial year, the name of Stock Exchange to which it would pay the fine in case of shortfall in the mandatory borrowing through debt markets.
22-04-2024
Bigul

Vineet Laboratories Ltd - 543298 - Certificate Under Regulation 40(9) And 40(10) Of The Securities Exchange Board Of India (Listing Obligations And Disclosure Requirements) Regulations, 2015

We are hereby enclosing the certificate received from the Practicing Company Secretary for the financial year ended on March 31, 2024.
13-04-2024
Bigul

Vineet Laboratories Ltd - 543298 - Compliance Certificate Under Regulation 7(3) Of Securities And Exchange Board Of India (Listing Obligations And Disclosure Requirements) Regulations, 2015 For The Financial Year Ended On March 31, 2024.

We are herewith submitting the certificate ensuring all activities in relation to Share Transfer Facility are maintained by the Registrar to an issue and share transfer agent - Venture Capital and Corporate Investments Private Limited, which is registered with SEBI under registration number: INR000001203.
12-04-2024
Bigul

Vineet Laboratories Ltd - 543298 - Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018

We are hereby submitting the certificate issued by Venture capital and Corporate Investments Private Limited for the fourth quarter and financial year ended on March 31, 2024
12-04-2024
Bigul

Vineet Laboratories Ltd - 543298 - Closure of Trading Window

The trading window for dealing in the securities of the Company will remain closed from April 1, 2024 till 48 hours after the announcement of Standalone Audited Financials Results for the Fourth Quarter and the Financial Year ended on March 31,2024. for all the designated persons, their immediate relatives and all the connected persons covered under the code. The Company has ensured freezing of PAN of all the designated persons and their immediate relatives during the period of trading window closure.
29-03-2024
Bigul

Vineet Laboratories Ltd - 543298 - Announcement under Regulation 30 (LODR)-Newspaper Publication

Newspaper Publication of the Unaudited Financial Results for the Third Quarter and Nine months ended on December 31, 2023.
14-02-2024
Bigul

Vineet Laboratories Ltd - 543298 - Board Meeting Outcome for Outcome For The Board Meeting Held On Monday, February 12, 2024, As Required Under Regulation 30 Of The Securities And Exchange Board Of India (Listing Obligations And Disclosure Requirements) Regulations, 2015

The Board of Directors in its meeting held today i.e., on February 12, 2024, has considered and approved the unaudited Financial results of the Company for the Third Quarter and the Nine months ended on December 31, 2023
12-02-2024
Bigul

Vineet Laboratories Ltd - 543298 - Unaudited Financial Results Along With Limited Review Report For The Third Quarter And Nine Months Ended 31St December 2023.

Unaudited Financial Results and Limited Review Report for the Third Quarter and the Nine months ended 31st December 2023.
12-02-2024
Bigul

Vineet Laboratories Ltd - 543298 - Board Meeting Intimation for Intimation Of The Date Of Board Meeting Under Regulation 29 Of SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015

Vineet Laboratories Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 12/02/2024 ,inter alia, to consider and approve unaudited financial results of the Company for the 3rd quarter and the nine months period ended on December 31, 2023 along with the Limited Review Report
02-02-2024
Bigul

Vineet Laboratories Ltd - 543298 - Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018

Certificate under Regulation 74(5) of SEBI(Depository and Participants) Regulations, 2018 for the Quarter ended December 31, 2023
05-01-2024
Next Page
Close

Let's Open Free Demat Account